Related Experiment Video
Updated: Jun 1, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Diffuse large B-cell lymphoma complicated with autoimmune thrombocytopenia
Michihiro Uchiyama1, Kota Sato, Takashi Ikeda
1Department of Hematology, Suwa Red Cross Hospital, Japan. mi.uchiyama@suwa.jrc.or.jp
Internal Medicine (Tokyo, Japan)
|June 2, 2011
Summary
Chemotherapy effectively treated autoimmune thrombocytopenia and diffuse large B-cell lymphoma (DLBCL). Other therapies like steroids and rituximab failed, highlighting the need for more research into this rare condition.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Autoimmune thrombocytopenia (ITP) is a rare complication in patients with malignant lymphoma.
- Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma.
Observation:
- A patient presented with concurrent ITP and DLBCL.
- Initial treatments including steroid therapy, rituximab monotherapy, and high-dose glucocorticoid with intravenous immunoglobulin were ineffective for ITP.
Findings:
- Chemotherapy demonstrated success in treating both ITP and DLBCL in this patient.
- This case highlights the variable response of ITP to different treatment modalities when co-occurring with lymphoma.
Implications:
- Further investigation into the pathogenesis of ITP in lymphoma patients is warranted.
- Optimal treatment strategies for concurrent ITP and DLBCL require further clarification through case studies and research.
Related Concept Videos
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...